2022 - Research.com Immunology in Norway Leader Award
The scientist’s investigation covers issues in Immunology, Lymphokine-activated killer cell, Interleukin 12, Interleukin 21 and NK Cell Lectin-Like Receptor Subfamily C. Karl-Johan Malmberg has included themes like Cancer research and Transplantation in his Immunology study. His Lymphokine-activated killer cell study incorporates themes from Natural killer cell and Cell biology.
His research investigates the link between Cell biology and topics such as Cytotoxic T cell that cross with problems in DNA methylation, Effector and Acquired immune system. The concepts of his NK Cell Lectin-Like Receptor Subfamily C study are interwoven with issues in Virus and Innate immune system. His Virus study deals with Human leukocyte antigen intersecting with KIR2DS4.
His main research concerns Immunology, Cell, Cell biology, Cytotoxic T cell and Natural killer cell. His studies examine the connections between Immunology and genetics, as well as such issues in Interleukin 12, with regards to Acquired immune system. His Cell research is multidisciplinary, relying on both Cancer research, Cytokine, Cancer immunotherapy, Receptor and Interleukin 15.
His research integrates issues of Phenotype and Reprogramming in his study of Cell biology. His Cytotoxic T cell research is multidisciplinary, incorporating elements of T cell, Degranulation and CD8. His work carried out in the field of Natural killer cell brings together such families of science as Gene and Major histocompatibility complex.
Karl-Johan Malmberg spends much of his time researching Cell, Cell biology, Cancer research, Natural killer cell and Cell therapy. His Cell research incorporates elements of Cytokine, Cancer immunotherapy, Perforin, Innate immune system and Interleukin 15. Innate immune system is a subfield of Immunology that Karl-Johan Malmberg investigates.
The Cell biology study combines topics in areas such as Cytotoxic T cell, Granzyme B and In vivo. Karl-Johan Malmberg has researched Cytotoxic T cell in several fields, including Cell culture, Human leukocyte antigen and Stem cell. He regularly links together related areas like Receptor in his Natural killer cell studies.
Karl-Johan Malmberg mostly deals with Cell, Receptor, Cell biology, Innate immune system and Natural killer cell. His work in the fields of Cell, such as Cell therapy, intersects with other areas such as Induced pluripotent stem cell. His studies deal with areas such as Bile duct cancer, Immunology, Immune system, Liver cancer and Primary sclerosing cholangitis as well as Receptor.
His work in Cell biology addresses subjects such as Interleukin 15, which are connected to disciplines such as Immunotherapy and Cell culture. His biological study spans a wide range of topics, including Cytokine, Cell type, Granzyme B, Intracellular and Degranulation. His PI3K/AKT/mTOR pathway study combines topics in areas such as Reprogramming and Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren;Karl-Johan Malmberg.
Nature Reviews Immunology (2007)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Björkström;Peggy Riese;Frank Heuts;Sandra Andersson.
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus
Niklas K. Björkström;Therese Lindgren;Malin Stoltz;Cyril Fauriat;Cyril Fauriat.
Journal of Experimental Medicine (2011)
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Heinrich Schlums;Frank M Cichocki;Frank M Cichocki;Bianca Tesi;Jakob Theorell.
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRS
Vivien Béziat;Lisa L. Liu;Jenny-Ann Malmberg;Martin A. Ivarsson.
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon.
European Journal of Immunology (2012)
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
Cyril Fauriat;Martin A. Ivarsson;Hans-Gustaf Ljunggren;Karl-Johan Malmberg.
DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells
Mattias Carlsten;Niklas K. Björkström;Håkan Norell;Yenan Bryceson.
Cancer Research (2007)
Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.
Yang Rongcun;Flavio Salazar-Onfray;Jehad Charo;Karl Johan Malmberg.
Journal of Immunology (1999)
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
Karl Johan Malmberg;Victor Levitsky;Håkan Norell;Cristina Teixeira De Matos.
Journal of Clinical Investigation (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: